A to Z subjects
Find stories by subject. Use the A-Z options to view other subjects.
All
- 177Lu-labeled FAPI-RGD
- 2seventy bio
- 3D printing
- 89bio
- A*STAR
- Aamir Malik
- AB-1005
- AbbVie
- AbbVie Inc.
- Abdullah Baqui
- Abecma
- Abecma (idecabtagene vicleucel)
- abelacimab
- Abeona Therapeutics
- Abigail Harris
- ABL Bio
- ABPI (Association of the British Pharmaceutical Industry)
- Abrysvo
- Abzena
- AC Immune SA
- Academy of Medical Sciences
- Access to Medicine Foundation
- Accugenix
- ACD Labs
- ACI-24.060
- acid sphingomyelinase deficiency
- acne vulgaris
- acoramidis
- Acromegaly
- active psoriatic arthritis (PsA)
- Actylis
- acute lymphoblastic leukaemia
- Acute lymphoblastic leukaemia (ALL)
- Acute migraine
- Acute myeloid leukaemia (AML)
- acute myeloid leukemia
- Adaflex
- Adakveo (crizanlizumab)
- Adam Berman
- Adam Pearson
- Adaptimmune
- ADBRY
- Adcetris
- Adempas
- adenocarcinoma
- Adi Kaushal (Lonza)
- Adragos Pharma
- Adrian van den Hoven
- Adriana Kiędzierska-Mencfeld
- Adrienne Brown
- adsorbed))
- Adstiladrin (nadofaragene firadenovec-vncg)
- Adtralza (tralokinumab)
- Aduhelm (aducanumab-avwa)
- advanced prostate cancer
- Advanced therapies manufacturing
- Advanced therapies manufacturing dup
- Advanced Therapies Treatment Centre (ATTC)
- ADVANZ PHARMA
- Advent
- Aflibercept
- AGB-Pharma
- AGC Biologics
- age-related macular degeneration (AMD)
- Agilent Technologies
- Agilent Technologies Inc
- Ahmad Amini (Swedish Medical Products Agency)
- AI, analytics and decision support
- AIDS
- Aileen Pangan
- Airborne particle counting
- AJOVY
- Alastair MacKinnon
- Albert Bourla
- Alecensa® (alectinib)
- Alessio Zoccoli
- Alex Del Priore
- Alexandre de Germay
- Alexion
- Alexion Pharmaceuticals
- Ali Hassanpour (University of Leeds)
- Alison Labya
- Alistair Macdonald
- Alkermes
- Allergies
- Alliance for Regenerative Medicine (ARM)
- Almac
- Almac Pharma Services
- Almirall
- Alnylam Pharmaceuticals
- alopecia areata (AA)
- alpha-1 antitrypsin deficiency (AATD)
- AlphaMedix
- Altasciences
- Altruist Biologics
- Alvotech
- Alyftrek
- Alzheimer’s disease
- Alzheimer's
- Amanda Cunnington
- Amelie Quilichini
- Amgen
- Amgen Inc
- Ami Polymer
- amlodipine
- amoxicillin
- AMR Industry Alliance
- Amtagvi (lifileucel)
- Amvuttra
- Amy Bobbins
- Amyloidosis
- amyotrophic lateral sclerosis (ALS)
- Anabela Cardoso
- Anaelle Tannen
- anaemia
- Analytical and bioanalysis
- anaphylaxis
- Andelyn Biosciences
- Andrew Gwynne
- Andrew Mears
- Andrew Stephenson
- AnGes
- Anju Bhalla
- Anktiva (nogapendekin alfa inbakicept)
- Anna Leach
- Annaliesa Anderson
- Anne Kerber
- Anne White
- Annelies Van Dycke
- Antibiotic resistance
- Antibiotics
- Antibiotics
- antibody drug conjugate (ADC)
- Antibody Drug Conjugates
- antibody oligonucleotide conjugates
- Anti-Cancer Therapeutics
- Anticoagulants
- Antidepressants
- antimicrobial resistance (AMR)
- anti-PD-1 inhibitor
- Anxiety
- apitegromab
- Aplidin (plitidepsin)
- Appointments
- Archimedis Digital
- Arexvy
- Argenx
- Arizton
- Armin Spura
- ARS Pharmaceuticals
- Arvinas Inc
- Asahi Kasei
- ASC50
- Ascendis Pharma
- Ascletis Pharma
- Aseptic Processing
- Ashley Woodcock
- AskBio
- Asklepios BioPharmaceutical
- Aspen Pharma Trading Limited
- Assays
- Associates of Cape Cod
- Associates of Cape Cod International
- Association of the British Pharmaceutical Industry (ABPI)
- Association of the European Self-Care Industry (AESGP)
- Astellas
- Astellas Pharma
- Astellas Pharma Inc.
- Asthma
- AstraZeneca
- ATCC
- atezolizumab
- atherosclerosis
- Atherosclerotic cardiovascular disease (CVD)
- Athlone Laboratories
- atogepant
- Atopic Dermatitis
- atorvastatin
- Atrial Fibrillation
- Atropine sulfate FGK (atropine)
- attention-deficit/hyperactivity disorder (ADHD)
- Attrogy
- Aucatzyl (obecabtagene autoleucel)
- Aumseqa (aumolertinib)
- Aurobindo
- Australian Department of Health and Aged Care
- Autism
- Autism spectrum disorder
- Autoimmune diseases
- autoimmune disorders
- Automation and robotics
- autosomal dominant polycystic kidney disease
- Avacincaptad Pegol (ACP)
- Avidity Biosciences
- Avivia
- Awiqli
- Axial Spondyloarthritis
- Axplora
- Ayrmid
- AZD5004
- AZD6234
- AZD9550
- azithromycin
- bacterial infections
- Bassem Saleh
- Baxdrostat
- Bayer
- Bayer AG
- Bayes Business School
- BBL
- B-cell acute lymphoblastic leukaemia
- B-cell Lymphoma
- BD ChloraPrep Clear
- beclometasone dipropionate
- Becton Dickinson UK Ltd
- bedaquiline
- BeiGene
- BeiGene Ltd.
- Belén Garijo
- Belinda Byrne
- bemarituzumab
- Bemdaneprocel (BRT-DA01)
- Ben Jones
- Ben Palleiko
- bendamustine
- Benedikt von Braunmühl
- BEQVEZ (fidanacogene elaparvovec-dzkt)
- Berlin Institute of Health
- Bernd Kasper
- Beta blockers
- Beth Pope
- bevacizumab
- BEXSERO
- Beyfortus
- Beyonttra
- Bicycle Therapeutics
- Big Pharma
- Biktarvy (bictegravir)
- biliary tract cancer
- Bill Martin
- Bimervax
- Bimzelx
- Bimzelx (bimekizumab)
- Bindhu Gururajan (Novartis)
- Bio Products Laboratory
- Bio Products Laboratory Limited (BPL)
- BioArctic
- Bioassays, potency and characterisation
- Bioassays, potency and characterisation dup
- Biocon Biologics
- BioDuro
- Biogen
- BioGrad
- BioIndustry Association (BIA)
- Biologics formulation and stability
- bioMérieux
- bioMerieux SA
- Bionova Scientific
- BioNTech
- BioNTech SE
- biopharmaceuticals
- Bioprocessing and biomanufacturing
- Biotech
- Biotechnology Innovation Organization (BIO)
- Biovectra
- BioXcellence
- bipolar disorder
- bispecific antibody
- Biswajit Podder
- Bladder cancer
- Blenrep (belantamab mafodotin)
- Blincyto (blinatumomab)
- Blockchain
- Blood cancer
- BlueRock Therapeutics LP
- Blujepa (gepotidacin)
- BNT327
- Boehringer Ingelheim
- Bok-Ki Kang
- Bomyntra (denosumab)
- bone cancer
- bone loss
- Boris Zaïtra
- Boston Pharmaceuticals
- Boumediene Soufi (Sandoz)
- Brain cancer
- Brandee Pappalardo
- Brandon Fincher (Cambrex)
- BRCA1
- Breast cancer
- Brendan O’Callaghan (Sanofi)
- Brensocatib
- Breyanzi
- Breyanzi (lisocabtagene maraleucel)
- Brian McNamee
- Brian Morrissey
- Brian Wong
- BridgeBio Gene Therapy
- BridgeBio Pharma
- Brinsupri (brensocatib)
- Bristol Myer-Squibb
- Bristol-Myers Squibb
- Bristol-Myers Squibb (BMS)
- Bristol-Myers Squibb Foundation
- British Standards Institute (BSI)
- British Standards Institution
- bronchiectasis
- Bruce Lahn (VectorBuilder)
- Bruce Thompson
- Bruce Vielle
- Bruker
- Bruker Corporation
- BRUKER MICROBIOLOGY & INFECTION DIAGNOSTICS
- BRUKINSA® (zanubrutinib)
- Bruno Fabre
- Bryan Kim
- business news
- busulfan
- Byoungin Jung
- C. Difficile
- cabotegravir
- CagriSema (cagrilintide + semaglutide)
- Caliber Technologies
- Calquence
- Calquence (acalabrutinib)
- CAM2029
- Cambrex
- Cambridge University
- Camfil
- Campbell Bunce
- Canada Drug Agency (CDA-AMC)
- Cancer
- Cannabinoids
- Cannabis
- Capivasertib
- Caplyta (lumateperone)
- Capstan Therapeutics
- Capvaxive (pneumococcal polysaccharide conjugate vaccine (21-valent))
- carboplatin
- Cardiovascular disease
- cardiovascular disease (CVD)
- Carinne Brouillon
- Carlos Velez
- Caroline Peachey (European Pharmaceutical Review)
- Carrie Mason (Lonza)
- carvedilol
- Carvykti (ciltacabtagene autoleucel)
- Case Western Reserve University School of Medicine
- Casgevy
- Catalent
- Catalent Biologics
- Catherine Drew
- CD34+ cells (Protheracytes®).
- CDMO/CMO operations
- Cedrik Neike
- Celadon Pharmaceuticals
- Celea Therapeutics
- Céline Koelbert (Novartis)
- Cell and Gene Therapy Catapult
- Cell and Gene Therapy Catapult (CGTC)
- Cell culture automation
- Cellix
- CellProthera
- Celltrion
- Cellular Imaging & Analysis (CIA)
- Center for Biologics Evaluation and Research (CBER)
- Center for Drug Evaluation and Research (CDER)
- Centre for Process Innovation (CPI)
- Cerevel Therapeutics
- Cervical cancer
- Cervicorn Consulting
- cGMP
- ChAd3 Ebola Sudan vaccine
- Charité – Universitätsmedizin
- Charles Gore
- Charles River
- Charles River Laboratories
- Charles River Laboratories International
- chemotherapy
- Chemotherapy
- chemotherapy induced peripheral neuropathy (CIPN)
- Chia Tai Tianqing Pharmaceutical Group
- Chiara Celli (Institute of Biomedical Research Antoine Marxer)
- Chiesi
- Chiesi Farmaceutici SPA
- Chiesi Global Rare Diseases
- Chiesi Group
- Chiesi UK and Ireland
- Chikungunya virus
- Chip Baird
- Chitose Laboratory
- Cholesterol
- Chris Boerner
- Chris McDonald
- Christian Hauer
- Christian Schade
- Christiane Bardroff
- Christina Egelund
- Christina Gkousgkouni (Sanofi)
- Christine Caruso (Merck and Co)
- Christophe Bourdon
- Christophe Weber
- Christopher Austin
- Christopher Boerner
- Christopher Viehbacher
- Chromatography and separations
- chronic heart failure
- chronic kidney disease (CDK)
- chronic kidney disease (CKD)
- Chronic lung disease
- Chronic lymphocytic leukaemia (CLL)
- chronic obstructive pulmonary disease (COPD)
- chronic pain
- Chronic spontaneous urticaria (CSU)
- Ciltacabtagene autoleucel (cilta-cel)
- Cimzia (certolizumab pegol)
- Cindy Perettie
- Cipla
- Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA)
- Claire D'Abreu Hayling
- Claire Lund
- Clare Blue
- Clarivate PLC
- Claude Bertrand
- Cleveland Clinic
- Clifford Chance
- Clifford Rossi (University of Maryland)
- Clinical Development
- Clinical Trials
- Clostridioides difficile
- CNX Therapeutics
- Cobenfy
- Cold Chain Supply
- Collategene
- Colorectal cancer
- Columvi
- Columvi (glofitamab)
- COMIRNATY®
- Committee for Medicinal Products for Human Use (CHMP)
- COMPASS Pathways
- Complicated urinary tract infections
- Conexxence (denosumab)
- Confederation of British Industry (CBI)
- Continuous manufacturing and PAT
- Contivue
- Contract Research Organisations (CROs)
- Controlled release and advanced delivery
- Corden Pharma
- Coronavirus
- Corticosteroids
- Council of Europe (EDQM)
- Courtney Soulsby (BSI)
- Courtney Wachtel (Charles River Laboratories)
- Courtney Wachtel (Charles River)
- Covid-19
- COVID-19 Vaccine Moderna
- CPHI
- CPhI
- CPHI Frankfurt
- CPTX2309
- Creyon Bio
- CRISPR Therapeutics
- Crohn's disease (CD)
- Cryoport
- Cryoport Systems
- CSL
- CSL Behring
- CSL Seqirus
- Cubrc
- CUTX-101
- cyclophosphamide
- Cystadrops
- Cystic Fibrosis
- Cytokine release syndrome (CRS)
- Cytokinetics
- cytomegalovirus (CMV)
- Daewoong Therapeutics
- Daiichi Sankyo
- Dame Chi Onwurah
- Dan Grossman
- Dana-Farber Cancer Institute
- Daniel Abate-Daga
- Daniel O’Day
- Daniella Cramp
- Danish Medicines Agency
- Danny Bar-Zohar
- Danny Nguyen
- danuglipron
- daratumumab (Darzalex®)
- Darius Hughes
- Dark Blue Therapeutics
- Darren Head
- Darzalex
- Data Analysis
- Data Bridge Market Research
- Data integrity
- Datopotamab deruxtecan (Dato-DXd)
- Datroway (datopotamab deruxtecan)
- Dave Elder (David P Elder Consultancy)
- Dave Fredrickson
- Dave Ross
- Dave Tudor
- David Elder (David P Elder Consultancy)
- David Loew
- David P Elder Consultancy
- David Ricks
- David Wald
- David Weinreich
- David Westberg
- David Zaccardelli
- Dazluma
- Dazublys
- DBT 3757
- Deafness
- Debbie Cenziper
- Deborah Persaud
- Deborah Waterhouse
- delpazolid
- Dementia
- Denbrayce
- Dennie van den Heuvel
- Denosumab
- Depression
- Deqsiga (human normal immunoglobulin)
- desmoid tumour
- deupirfenidone
- Devang Bhuva
- dexamethasone (DVD)
- dexlansoprazole
- Diabetes
- diabetes mellitus
- diabetic macular edema
- diabetic macular oedema
- diabetic retinopathy
- diffuse large B-cell lymphoma (DLBCL)
- diflunisal
- Digital and Pharma 4.0
- Digital twins
- Diogo Rau
- Direct oral anticoagulants (DOACs)
- Dissolution Testing
- Distribution & Logistics
- DNA
- Donald Trump
- donanemab
- Doug Ingram
- Dovato (dolutegravir/lamivudine)
- Downstream purification
- doxorubicin
- Dr Agnieszka Czechowicz
- Dr Akhilesh Kumar Kuril (Flamma USA)
- Dr Alan Whone
- Dr Albert Bourla
- Dr Alyssa Johnsen
- Dr Amy Paller
- Dr Andrea Pfeifer
- Dr Andrew Hershey
- Dr Arash Mostaghimi
- Dr Aravindhan Veerapandiyan
- Dr Arun Sanyal
- Dr Becky Upton
- Dr Bill Lundberg
- Dr Bill Martin
- Dr Brittany Craiglow
- Dr Byron Lam
- Dr Carl Awh
- Dr Carl June
- Dr Carmen Bozic
- Dr Carol Routledge
- Dr Carole Ho
- Dr Chris Boshoff
- Dr Chris Chen
- Dr Christian Baber
- Dr Christian Ruff
- Dr Cristian Massacesi
- Dr Cristina Trujillo
- Dr Daejin Abidoye
- Dr Daniel Mahony
- Dr Daniel Skovronsky
- Dr Dave Berry (CPI)
- Dr David Soergel
- Dr Dean Li
- Dr Deborah Bitterfield
- Dr Diego Ardigò
- Dr Diego Ferone
- Dr Doug Botkin
- Dr Doug Botkin (Charles River)
- Dr Edmond Chan
- Dr Emerson C Perin
- Dr Eric Hughes
- Dr Esi Lamousé-Smith
- Dr Fausto Artico
- Dr Flavius Martin
- Dr Frank Jiang
- Dr Gabi Belfort
- Dr George Yancopoulos
- Dr Gunnar Sachs
- Dr Guy Goodwin
- Dr Helen Evans-Howells
- Dr Houman Ashrafian
- Dr Howard Fillit
- Dr Hui Zhou
- Dr Huma Qamar
- Dr Ivan Norena
- Dr Jaap Venema
- Dr Jack Hoppin (Ratio Therapeutics)
- Dr Jakub Svoboda
- Dr James Howard Jr
- Dr Janet Valentine
- Dr Janice Mehnert
- Dr Jason Clark
- Dr Jean Tang
- Dr Jean-Luc Herbeaux
- Dr Jeff Emmick
- Dr Jeffrey Cummings
- Dr Jennifer Isken (Novartis)
- Dr Jessy Cartier (Samabriva)
- Dr Jianmin Fang
- Dr Joe Wiley
- Dr John A (Chip) Scarlett
- Dr John Lazar
- Dr John Maher
- Dr John Ward
- Dr Jonathan Silverberg
- Dr Jordan Graff
- Dr Joseph Eid
- Dr June Raine
- Dr Katy Rezvani
- Dr Klaus Heumann
- Dr Kori Wallace
- Dr Levi Garraway
- Dr Lloyd Miller
- Dr Luhan Yang
- Dr Manish Saxena
- Dr Maoli Duan
- Dr Marc Riedl
- Dr Marc-Olivier Baradez (CGT Catapult)
- Dr María Martínez Hervés
- Dr Marianna Fontana
- Dr Mark Rutstein
- Dr Markus Warmuth
- Dr Marla Dubinsky
- Dr Martina Flammer
- Dr Matthew Klein
- Dr Megha Kaushal
- Dr Mehrdad Mobasher
- Dr Merdad Parsey
- Dr Michael James
- Dr Michael Thase
- Dr Michael Wang
- Dr Neil Johnston
- Dr Norbert Heinrich
- Dr Patricia Pozo-Rosich
- Dr Peter Lebowitz
- Dr Peter Marks
- Dr Primal Kaur
- Dr Priya Singhal
- Dr R Ananthanarayanan
- Dr Radhakrishna Tirumalai
- Dr Rajni Agarwal
- Dr Ramez Eskander
- Dr Rami Komrokji
- Dr Randall Bateman
- Dr Reddy’s
- Dr Reddy’s Laboratories Ltd
- Dr Richard Pazdur
- Dr Richard Torbett
- Dr Robert Bissonnette
- Dr Roopal Thakkar
- Dr Roxana Mehran
- Dr Samuel Zhang
- Dr Sara Tolaney
- Dr Sarah Sheikh
- Dr Sarah Tabrizi
- Dr Sebastian Stintzing (Charité University Hospital)
- Dr Sekar Kathiresan
- Dr Shaji Kumar
- Dr Sharon McGuinness
- Dr Shreeram Aradhye
- Dr Sia Daneshmand
- Dr Sitra Tauscher-Wisniewski
- Dr Sophie Castell
- Dr Steve Pakola
- Dr Surbhi Sidana
- Dr Susan Kohlhaas
- Dr Syed Shah
- Dr Tamara Werner-Kiechle
- Dr Tedros Adhanom Ghebreyesus
- Dr Thomas Fuchs
- Dr Thomas Hooton
- Dr Tiffany Farchione
- Dr Tina Minja
- Dr Tomas Aleman
- Dr Tony Cundell (Microbiological Consulting LLC)
- Dr Ugur Sahin
- Dr Uwe Gudat
- Dr Uwe Platzbecker
- Dr Vas Narasimhan
- Dr Vibha Jawa
- Dr Vijay Kumar
- Dr Vimal Hasmukh Prajapati
- Dr Vinay Prasad
- Dr Vladimir Makarov (The Pistoia Alliance)
- Dr Walid Abi-Saab
- Dr Weite Oldenziel
- Dr Yukiko Nakatani
- Dr Yves Dauvilliers
- Dr Mark Mintun
- Dr Michael Severino
- Dr Naimish Patel
- Dr Samit Hirawat
- Drew Hope
- Drew Weissman
- Dror Bashan
- Drug Counterfeiting
- Drug Development
- Drug Discovery
- Drug Markets
- Drug resistance
- Drug Safety Research Unit (DSRU)
- Drug Targets
- Drug toxicology studies
- Drug-device combination products
- Duchenne muscular dystrophy (DMD)
- Dupixent
- DUPIXENT (dupilumab)
- Duraisamy Rajan Palani
- duvakitug (TEV’574/SAR447189)
- Duvyzat
- Dyrupeg (pegfilgrastim)
- dystrophic epidermolysis bullosa (DEB)
- E. coli
- Eaisi
- Ebglyss (lebrikizumab)
- Ebola virus
- Ebvallo™ (tabelecleucel)
- Ed Cinca
- Ed Piper
- Ed Wilson
- Edgardo Hernandez
- Edita Hamzic
- Editorial
- Edwin van den Heuvel (Eindhoven University of Technology)
- efimosfermin alfa
- Eindhoven University of Technology
- Eisai
- Ekterly (sebetralstat)
- ELAHERE (mirvetuximab soravtansine-gynx)
- Elcin Barker Ergun
- Electronic Laboratory Notebooks (ELNs)
- Eleni Kounalakis
- Elevidys
- Elfabrio (pegunigalsidase alfa)
- Eli Lilly
- Eli Lilly & Company
- Eli Lilly and Company
- elinzanetant
- Eliquis
- Eliquis (apixaban)
- Eltrombopag Accord (eltrombopag)
- EMA Committee for Medicinal Products for Human Use (CHMP)
- EMA human medicines committee (CHMP)
- EMA Pharmacovigilance Risk Assessment Committee (PRAC)
- Emblaveo
- Emer Cooke
- Emerson
- Emma Walmsley
- emtricitabine
- Emtricitabine/Tenofovir alafenamide Viatris (emtricitabine / tenofovir alafenamide)
- endometrial cancer
- endometriosis
- Endotoxin
- Endotoxin Detection
- Enflonsia (clesrovimab)
- Enhertu
- Enhertu (trastuzumab deruxtecan)
- Ensera
- Entegris
- Environmental Monitoring
- Enwylma
- Enzene
- enzyme replacement therapy (ERT)
- eosinophilic esophagitis
- epidermal growth factor receptor inhibitors (EGFRi)
- Epilepsy
- episodic migraine
- Epivax
- Epysqli (eculizumab)
- Esbriet
- Eschbach
- ESG and regulatory drivers
- Esteve
- Ethenzamide
- Eurneffy (epinephrine)
- Eurofins Scientific
- European Chemicals Agency (ECHA)
- European Commission
- European Commission (EC)
- European Council
- European Directorate for the Quality of Medicines (EDQM)
- European Directorate for the Quality of Medicines and Healthcare (EDQM)
- European Federation of Pharmaceutical Industries and Associations (EFPIA)
- European Medicines Agency (EMA)
- European Parliament
- European Patent Office (EPO)
- European Pharmaceutical Review
- European Pharmacopoeia (Ph. Eur.)
- European Pharmacopoeia (Ph. Eur.) Commission
- European Society for Blood and Marrow Transplantation
- Evonik Industries
- Evotec
- Evy Reviers
- Exagamglogene autotemcel (exa-cel)
- Excipients and raw materials
- eXmoor Pharma
- Exothera
- Exscientia
- Extensive-stage small cell lung cancer (ES-SCLC)
- EY
- Eye disease
- Eylea (afilibercept)
- Ezmekly (mirdametinib)
- F. Hoffmann La Roche AG
- Fabhalta
- Fabhalta (iptacopan)
- Fabrizio Lecce (Institute of Biomedical Research Antoine Marxer)
- Fabry disease
- Facilities, utilities and cleanrooms
- facioscapulohumeral muscular dystrophy
- Fact.MR
- Faecal microbiota transplantation (FMT)
- Fanconi anaemia
- farabursen
- Farxiga (dapagliflozin)
- Faye Feller
- fenebrutinib
- Feng Ren
- Ferring Pharmaceuticals
- Fezolinetant
- FG-M701
- fibrodysplasia ossificans progressive
- fibrosis
- Fieldfisher
- Fill-finish and sterile manufacturing (process)
- Finlee (dabrafenib)
- Fiona du Monceau
- Fiona Marshall
- Fitusiran
- Flamma USA
- flu
- fluoxetine
- Follicular Lymphoma
- Fondazione Telethon
- Forge Biologics
- formoterol fumarate
- Formulation and drug delivery
- Forxiga (dapagliflozin)
- Fouad Atouf (USP)
- Fragomen
- Francesca Blythe
- Francis Karanu (Likarda)
- Francis O’Doherty
- Frank Millar
- Fraunhofer IESE
- Fred Ayers (ValSource)
- Frederique Vieville
- Fredrik Lindberg
- Freeze Drying
- fremanezumab
- Fresenius
- fruquintinib
- Fujifilm
- Fujifilm Biosciences
- Fujifilm Biotechnologies
- FUJIFILM Biotechnologies UK
- Fujifilm Diosynth Biotechnologies
- FUJIFILM Wako
- FUJIFILM Wako Europe GmbH
- FUJIFILM Wako Pure Chemical Co. Ltd.
- fulvestrant
- Funding
- fungal infections
- furosemide
- Future Market Insights (FMI)
- FutureGen Biopharmaceutical
- Fuzhong Zhang
- Gabriele Razzetti
- Gaby Bourbara
- Gaelic Laboratories
- galactosaemia
- Galapagos
- Gamida Cell
- gantenerumab
- gastric cancer (GC)
- gastroenteropancreatic neuroendocrine tumours
- gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
- gastrointestinal stromal tumours (GIST)
- Gates Foundation
- Gattefossé
- Gelteq
- gemcitabine
- Genentech
- Generalised myasthenia gravis (gMG)
- generalised pustular psoriasis
- generic oncology drugs
- Generics
- Generics
- Genetic disorders
- Genmab A/S
- geographic atrophy
- George El-Helou
- George Freeman
- George Freeman MP
- George Tidmarsh
- gepotidacin
- Geron
- Geron Corporation
- Giacomo Chiesi
- giant cell tumour of bone
- Gilead Sciences
- Gilead Sciences Inc
- Gill Lewis (eXmoor Pharma)
- Giovanni Traverso (MIT)
- givinostat
- GlaxoSmithKline
- GlaxoSmithKline (GSK)
- Glenn Gerecke (Sandoz)
- Glioblastoma (GBM)
- glioma
- GlobalData
- GlobalData Pharma
- glofitamab
- glucagon-like peptide 1 (GLP-1) agonists
- glucocorticoids
- GMP and quality management systems (QMS)
- Gobivaz
- Good Distribution Practice (GDP)
- GRAd-COV2
- Graeme Bones (ICON)
- graft-versus-host disease (GvHD)
- Green Elephant Biotech
- Greg Hookings (Stratus Technologies)
- Gregory Webster (AbbVie)
- Growth Hormone Deficiency (GHD)
- GSK
- GTCR
- Guillaume Pinon
- Gunilla Osswald
- haematological malignancies
- haematology
- Haemolytic anaemia
- haemolytic disease
- haemolytic disease of the foetus and newborn (HDFN)
- haemophilia
- haemophilia A
- haemophilia B
- Halozyme Therapeutics
- Hangzhou Qihan Biotech Co.
- Hannah Hans
- Harry Jennings (VWV law)
- Head and Neck Cancer
- Headaches
- Heads of Medicines Agencies (HMA)
- Hearing loss
- heart disease
- heart failure
- heart failure with reduced ejection fraction (HFrEF)
- Helen Brain
- Helen Knight
- Heligan Group
- Helmholtz-Zentrum Dresden-Rossendorf
- Hemgenix
- Henna Virkkunen
- Henning Gieseler (FAU Erlangen-Nürnberg)
- Henrik Wulff
- Henry Gosebruch
- Henry Levy
- hepatitis C
- Hepatitis C (HCV)
- hepatitis delta virus (HDV)
- hepatocellular carcinoma (HCC)
- Hepcludex® (bulevirtide)
- HER2-negative breast cancer
- HER2-positive breast cancer
- HER2-positive metastatic breast cancer
- Herbal & Plant-Based Medicines
- Hereditary Angioedema (HAE)
- Hervé Affagard (MaaT Pharma)
- Hesham Abdullah
- Hexagon
- Heyo Kroemer
- Hidradenitis suppurativa (HS)
- high blood pressure
- Hilary Evans-Newton
- HIV
- HIV (Human Immunodeficiency Virus)
- HLD-0915
- Hodgkin lymphoma
- hormone-receptive positive breast cancer
- Hospital-acquired bacterial pneumonia (HABP)
- Hoth Therapeutics
- Houman Ashrafian
- Hovione
- Howard Mayer
- HPLC
- HR-positive
- HRS-5346
- HTS (High Throughput Screening)
- Hubertus von Baumbach
- Human Genome Sciences
- human metapneumovirus (hMPV).
- Humira (adalimumab)
- Huntington disease
- hyaluronidase
- hyperkalaemia
- hyperphenylalaninaemia
- hyperphenylalaninemia
- hypertension
- hypoparathyroidism
- Ian Ashurst
- Ian Betteridge (RPL)
- Ian Rees
- ianalumab
- IBI3001
- IBI343
- IBI363
- Ibon Garitaonandi (CellProthera)
- Ibrance (palbociclib)
- ICH guidelines
- ICON
- ICON plc
- icotrokinra
- ICT01
- IDE Group
- Idiopathic pulmonary fibrosis (IPF)
- IDRx Inc
- IDRX-42
- IgA nephropathy
- Ilaria Villa
- Ilya Yuffa
- IMA Pharma
- Imaavy
- Imbruvica
- ImCheck Therapeutics
- Imetelstat
- Imfinzi
- Imfinzi (durvalumab)
- immune thrombocytopenia (ITP)
- ImmunoGen
- Immunotherapy
- Immunotherapy
- Imperial College London
- Impurities, contaminants and nitrosamines
- Imran Kausar
- Inc.
- Incyte
- Indian Pharmacopoeia Commission (IPC)
- Industry Insight
- infectious diseases
- inflammation
- Inflammatory Bowel Disease
- inflammatory-bowel disease (IBD)
- Influenza
- Informa
- Informa Markets
- Ingredients
- Inherited retinal disease
- Inhixa
- INLEXZO™ (gemcitabine intravesical system)
- Innovate UK
- Innovative Health Initiative (IHI)
- Innovent Biologics
- InProcess-LSP
- InsightAce Analytic Pvt. Ltd
- Insilico Medicine
- Insmed Incorporated
- Insomnia
- Institute for Clinical and Economic Review (ICER)
- Institute for Technology Assessment in Health (IETS)
- Institute of Biomedical Research Antoine Marxer
- Insulin
- insulin icodec
- INT2104
- Interius BioTherapeutics
- International AIDS Vaccine Initiative (IAVI)
- International Council for Harmonisation (ICH)
- International Generic and Biosimilar Medicines Association (IGBA)
- International Organization for Standardization (ISO)
- International Society for Pharmaceutical Engineering (ISPE)
- Internet of Medical Things (IoMT)
- INTERPHEX
- interstitial lung disease
- Interviews
- Intra-Cellular Therapies
- investment
- Ionis Pharmaceuticals
- Iovance Biotherapeutics
- ipidacrine
- Ipsen
- iptacopan
- IQVIA
- Irena Maragkou
- Irish medicines regulatory agency
- Isabella Jul-Jørgensen (Technical University of Denmark)
- ischemic heart failure
- Isma Hachi
- Israel Stern
- Itovebi
- Itovebi (inavolisib)
- ivacaftor
- Iveric Bio
- IXCHIQ®
- Izabela Leszczyna
- izalontamab brengitecan
- Izamby
- J. Alex Kelly
- Jacob Sten Petersen
- Jacob Van Naarden
- Jacqueline Barry (CGT Catapult)
- Jan van de Winkel
- Jane Wall
- Janssen
- Janssen EMEA
- Janssen Pharmaceutical Companies of Johnson & Johnson
- Janssen Pharmaceuticals
- Janus kinase (JAK) inhibitors
- Japanese Pharmacopoeia
- Jardiance
- Jascayd (nerandomilast)
- Jason Jones
- Jasper Morley
- Javier López-Belmonte
- Jay Benson
- Jay Bradner
- Jay Hagan
- Jay Patel
- Jaypirca
- Jaypirca™ (pirtobrutinib)
- Jean-Charles Wirth
- Jean-Christophe Tellier
- Jean-Francois Toussaint
- Jean-Luc Herbeaux
- Jemperli (dostarlimab)
- Jennifer Taubert
- Jerry Chih Wei Yu
- Jessica Rayser (Accugenix)
- Jessicca Rege (Alkermes)
- Jessika Roswall
- Jialin Xiang
- Jiangsu Hengrui Pharmaceuticals Co.
- Jihye Heo (Samsung Biologics)
- Jim Fox
- Jinzi Jason Wu
- Jivi
- JNJ-2113
- Joanna Dempsey
- Joaquin Duato
- Joe Edwards
- Joelle Fathi
- Johan Carlsson (Swedish Medical Products Agency)
- Johan Kahlström
- John C. Reed
- John Crowley
- John Murphy III
- John Oyler
- John Rim
- Johns Hopkins University
- Johns Hopkins University School of Medicine
- Johnson & Johnson
- Johnson & Johnson Innovative Medicine
- Johnson and Johnson
- Jon Kallay (Charles River)
- Jonathan Reynolds
- Josefine Sommer (Sidley Austin)
- JRS Pharma
- JSKN-003
- JSR Life Sciences
- Jubbonti® (denosumab-bddz)
- Julia Matros
- Julia Schueler
- Julian Beach
- Julie Anderson
- Julie Huynh (Gelteq)
- Julie Kim
- Julien Dodet
- Juliette White
- Julius Clinical
- Junod
- Just - Evotec Biologics
- juvenile idiopathic arthritis
- Kaerus Bioscience
- Kaftrio (ivacaftor/tezacaftor/elexacaftor)
- Kai Beckmann
- Kaivan Khavandi
- KalVista Pharmaceuticals Inc
- Kalydeco (ivacaftor)
- Karen Capper (AstraZeneca)
- Karen Zink McCullough
- Karin Shanahan
- Karin Smyth
- Katalin Karikó
- Kathy Zagaroli (Kiniksa Pharmaceuticals)
- Katy Newton
- Kay Ivey
- Kedrion Biopharma
- Ken Takeshita
- KER-0193
- Keren Haruvi
- Kevin Bruce (Rosilin CT)
- Kevin Bruce (Roslin CT)
- Kevin Lee
- Keytruda (pembrolizumab)
- KEYTRUDA®
- Kidney cancer
- Kidney disease
- kidney failure
- Kinase
- Kincell Bio
- Kindeva Drug Delivery
- Kiniksa Pharmaceuticals
- Kinselby (resminostat)
- Kisunla
- Kisunla (donanemab)
- Kit Erlebach
- Kite
- Kite Pharma
- Kizfizo (temozolomide)
- Konstantin Matentzoglu
- Koselugo (selumetinib)
- KRAZATI® (adagrasib)
- Kristian Siedler (Merck LS RTU GmbH)
- Krystal Biotech
- KVK-Tech
- Kyinsu
- Kymera Therapeutics
- Lab Equipment
- Labelling
- Laboratory Information Management Systems (LIMS)
- LABVANTAGE Solutions
- Lamine Mbow
- lamivudine
- large B-cell lymphoma
- Larry Pitcher
- Lars Fruergaard Jørgensen
- Lars Petersen
- Lars Rebien Sørensen
- Laura Shawver
- Laura Steele
- Laure Pomares Voisin (Catalent Biologics)
- Lawrence Tallon
- lazertinib
- Leber Congenital Amaurosis
- Lecanemab
- Legal
- Leila Jaafar-Thiel (Nuclidium AG)
- Lenacapavir
- Leo Varadkar TD
- Leqembi (lecanemab-irmb)
- Leslie Citrome
- Leucid Bio
- Leukaemia
- Levi Garraway
- Lianlian Jiang
- LIMS, ELN and lab informatics
- Lindsay Davies (ISCT)
- Lindus Health
- linezolid
- Liquid Chromatography - Mass Spectrometry (LC-MS)
- liraglutide
- Liraglutide (Saxenda)
- Litfulo (ritlecitinib)
- Liu Qiang
- Live biotherapeutic products (LBPs)
- Liver cancer
- liver disease
- Liz Kendall
- Liza O'Dowd
- Logistics
- Lokelma (sodium zirconium cyclosilicate)
- Long-acting injectable cabotegravir (CAB LA)
- Longeveron
- Lonza
- Lonza Capsules and Health Ingredients
- Lonza Group AG
- Lonza Pharma & Biotech
- Lonza QC Testing Solutions
- Lord O’Shaughnessy
- Lord Vallance
- lorundrostat
- lotiglipron
- Louise Rodino-Klapac
- LSD
- Ltd
- Luc Truyen
- Lucintel
- Ludovic Fenaux
- Ludovic Helfgott
- Luke Miels
- Luke Miels (GSK)
- Lund University
- Lung cancer
- Lung disease
- Lupin Europe
- Lupin Pharmaceuticals
- Lutathera (lutetium (177Lu) oxodotreotide)
- Lutathera (lutetium Lu 177 dotatate)
- LX9851
- Lymphoma
- Lyndra Therapeutics
- Lynelle Hoch
- Lynkuet
- Lynozyfic (linvoseltamab)
- Lynparza (olaparib)
- Maapliv (amino acids)
- MaaT Pharma
- macular oedema
- major depressive disorder (MDD)
- Malaria
- malignant pleural mesothelioma
- Mantle cell lymphoma (MCL)
- Manuela Herrlein
- maple syrup urine disease (MSUD)
- Marburg virus
- Marc Bailey
- Marc Dunoyer
- Marco Mingolla (Institute of Biomedical Research Antoine Marxer)
- Marco Soriani
- marginal zone lymphoma
- Maria Paola Chiesi
- maridebart cafraglitide
- Marjorie Green
- Mark Dickman (University of Sheffield)
- Mark Graham
- Mark Mintun
- Mark O’Connor
- Marketsandmarkets
- MarkNtel Advisors
- Martin Holst Lange
- Martin Meeson
- Martin Vogel (Janssen)
- Marty Makary
- Mass spectrometry and omics
- Massachusetts Institute of Technology (MIT)
- MasterControl
- Material Identification
- Matt Haines
- Matt Jennings
- Matthew Durdy
- MAVYRET (Glecaprevir/Pibrentasvir)
- Maxearn Limited
- MBV AG
- MDMA
- Medable
- medical cannabis
- Medical Marijuana
- Medical University of South Carolina (MUSC)
- medicinal cannabis
- Medicine and Healthcare products Regulatory Agency (MHRA)
- Medicines and Healthcare products Regulatory Agency
- Medicines and Healthcare Products Regulatory Agency (MHRA)
- Medicines for Europe
- Medicines Patent Pool (MPP)
- Medicxi
- Medipost
- Medi-Tech Insights
- Megan Rose
- Mehmet Oz
- Melanoma
- Melodie Bryce
- Memorial Sloan Kettering Cancer Center (MSK)
- MenABCWY
- Menarini Group
- Mene Pangalos (AstraZeneca)
- meningitis
- meningococcal disease
- Menkes disease
- Mental illness
- MENVEO
- Mercaptopurine
- Merck
- Merck & Co
- Merck & Co Inc.
- Merck and Co
- Merck KGaA
- Merck Research Laboratories
- Mergers & Acquisitions
- Meribel Pharma Solutions
- Merkel cell carcinoma
- Merus
- mesenchymal stem cells
- MET-097i
- MET-233i
- metabolic dysfunction-associated steatohepatitis (MASH)
- metachromatic leukodystrophy (MLD)
- Metastatic breast cancer
- metastatic castration-resistant prostate cancer (CRPC)
- Metastatic melanoma
- metastatic non-small lung cancer (NSCLC)
- metastatic triple-negative breast cancer (mTNBC)
- metformin
- Method development and validation
- Methotrexate
- Metsera
- METTLER TOLEDO
- Mettler-Toledo Thornton
- mFOLFOX6
- Michael Flanagan (Avidity Biosciences)
- Michael Osso
- Michael Young
- Michal Nitka
- Michel Pairet (Boehringer Ingelheim)
- Michelle Mitchell
- Microarrays
- Microbial Biological Manufacturing
- Microbiological Consulting LLC
- microbiome
- Microbiome therapeutics: microscope to medicine
- Microbiomes
- Microparticles
- microRNA
- migraine
- Miguel Hernández University (UMH)
- Mike Doustdar
- Mike Hannay
- Mike Tobyn (Bristol Myers Squibb)
- Mike Tommasco
- Mike Ward
- Mineralys Therapeutics
- Mirati Therapeutics
- Miriam Guest (AstraZeneca)
- mirikizumab
- Mirko Pauli (AbbVie)
- miRNA
- Mirna Vazquez
- mirvetuximab soravtansine
- MMI Associates
- mNexspike
- Models
- Moderna
- Mohit Verma
- Molly McGlaughlin
- Monkeypox
- monoclonal antibodies (mAbs)
- monoclonal antibody
- Monte Rosa Therapeutics
- Mould contamination
- Mounjaro
- Mounjaro (tirzepatide)
- Mount Sinai
- Mourad Mellal (Catalent)
- moxifloxacin
- mResvia (Respiratory Syncytial Virus (RSV) mRNA vaccine)
- mRNA
- mRNA vaccine
- mRNA-1083
- mRNA-1345
- MSD
- mucosal melanoma
- Multiple myeloma
- multiple myeloma (MM)
- Multiple sclerosis
- Multiple Sclerosis (MS)
- Multivariate data analytical techniques (MVA)
- mycophenolate mofetil
- mycosis fungoides
- Myelodysplastic syndrome (MDS)
- myelodysplastic syndromes (MDS)
- myelofibrosis
- myopia
- Myotonic Dystrophy Type 1
- Nagoya University
- Nanexa AB
- Nano-medicine
- Nanoparticles
- nanoparticles
- Nanoscope Therapeutics
- Naoki Okamura
- narcolepsy
- nasopharyngeal carcinoma
- Natalie Saunders (CGT Catapult)
- Nathalie Moll
- National Cancer Institute (NCI)
- National Health Care Institute (ZIN)
- National Health Service (NHS)
- National Institute for Health and Care Excellence (NICE)
- National Institute for Health and Care Research (NIHR)
- National Institute for Health and Clinical Excellence (NICE)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institutes of Health (NIH)
- Nazarbayev University School of Engineering and Digital Sciences
- N-Dimethyltryptamine (DMT)
- Neal Dunkinson
- Near Infrared Spectroscopy (NIR)
- Neil Almstead (PTC Therapeutic)s
- Neil Kelly
- Nello Mainolfi
- Nelson Labs
- neovascular age-related macular degeneration
- Neupogen (filgrastim)
- neuroblastoma
- Neurodegenerative disease
- Neurodegenerative diseases
- Neuroendocrine tumours (NETs)
- Neurofibromatosis type 1 (NF1)
- neuromuscular diseases
- neutropenia
- NewAmsterdam Pharma
- Ngenla
- NHS England
- NHS Kent and Medway Integrated Care Board
- NHS Scotland
- Nicolas Chornet
- Nicole Verdun
- nintedanib
- Nintedanib esilate
- nipocalimab
- Nippon Muki Co.
- Nirsevimab
- nitrofurantoin
- Nivolumab
- Nonalcoholic steatohepatitis (NASH)
- non-cystic fibrosis bronchiectasis
- non-Hodgkin lymphoma
- non-Hodgkin lymphoma (NHL).
- non-muscle invasive bladder cancer (NMIBC)
- non-small cell lung cancer (NSCLC)
- Norgine Pharmaceuticals Ltd
- Normand Blais
- Northwell Health
- Northwell Health’s Feinstein Institutes for Medical Research
- Novartis
- Novartis AG
- Novartis Gene Therapies
- Novartis Pharma AG
- Novartis Pharmaceuticals
- Novavax
- Novo Nordisk
- Novo Nordisk A/S
- Novo Nordisk Foundation
- NSF
- NSF International
- Nugalviq
- NunaBio
- Nuvaxovid
- obesity
- obicetrapib
- obinutuzumab
- Ocaliva
- Ocrevus (ocrelizumab)
- octreotide
- Ocugen
- Oczyesa
- oedema
- oesophageal cancer
- oesophageal squamous cell carcinoma
- Ofev
- Office of the Assistant Secretary for Preparedness and Response (ASPR)
- Ofichem
- Ogsiveo (nirogacestat)
- Ohtuvayre (ensifentrine)
- olaparib
- oligonucleotide
- Olivér Várhelyi (European Commission)
- Olivier Negre (Smart Immune)
- OLUMIANT® (baricitinib)
- Omega Therapeutics
- Omisirge (omidubicel-onlv)
- Omvoh
- Oncology
- Opdivo
- Opdivo (nivolumab)
- Ophelia Chan
- oral drugs
- Oral therapeutic candidate
- Orano med
- Orbital Therapeutics
- orforglipron
- Orhan Caglayan
- Orion Corporation
- Orphan Drugs
- Osaka Metropolitan University
- osteoporosis
- OTX-201
- Ovarian Cancer
- oveporexton
- Ozempic (semaglutide)
- ozureprubart
- pacibekitug
- Packaging, containers and labelling
- paclitaxel
- PADCEV
- Pain
- Pancreatic Cancer
- Pancreatic ductal adenocarcinoma (PDAC)
- paracetamol
- Parenteral Drug Association (PDA)
- Parenterals and sterile injectables
- Parkinson’s
- Parkinson's disease
- paroxysmal nocturnal haemoglobinuria (PNH)
- paroxysmal nocturnal hemoglobinuria (PNH)
- Particle Measuring Systems
- Parviz Shamlou
- Pascal Soriot
- Patents
- Patrick Lucy
- Patrick Mahieux (SK pharmteco)
- Patrik Jonsson
- Paul Evans
- Paul Hudson (Sanofi)
- Paul McKenzie
- Pavblu (aflibercept)
- PDA
- Pedmarqsi® (anhydrous sodium thiosulfate)
- pegfilgrastim
- pegozafermin
- pembrolizumab
- penicillin
- peripheral arterial disease (PAD)
- Perjeta (pertuzumab)
- PerkinElmer Inc.
- personalised medicine
- Personalised medicine
- Peter Benton
- Peter Kyle
- Peter Stenico (Sandoz)
- petosemtamab
- PF-06954522
- PF-07976016
- Pfizer
- phage therapy
- Pharmacokinetics
- Pharmacovigilance and safety oversight
- PharmaLab
- Pharmapack Europe
- phenylketonuria
- phenylketonuria (PKU)
- Phil Johnson
- Philips Electronics Nederland
- Pierre Wolkenstein
- Pieta Boon (MSD)
- Pinsent Masons
- Pipelines
- pirfenidone
- Pistoia Alliance
- plaque psoriasis
- plaque psoriasis (PsO)
- Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
- Pneumonia
- Politecnico di Milano
- Polphamra Biologics
- Polpharma Biologics
- polymers
- polyneuropathy
- Poppy Cliffe (AstraZeneca)
- Porton Pharma Solutions
- postpartum depression
- potassium bromide
- prazosin
- Preclinical Research
- prediabetes
- prednisone
- Pretomanid
- Prevymi
- primary biliary cholangitis (PBC)
- Primary progressive multiple sclerosis (PPMS)
- ProBioGen
- Processing
- Production
- Professor Andrea Manfrin
- Professor Andreas Meisel
- Professor Andrew Morris
- Professor Andrew Tutt
- Professor Antonio Ferrer Montiel
- Professor Asia Fernández
- Professor Atticus Hainsworth
- Professor Dame Ijeoma Uchegbu
- Professor Dame Jenny Harries
- Professor Dana Rizk
- Professor Eduard Vieta
- Professor Jacob George
- Professor James Chalmers
- Professor Jean Abraham
- Professor Johnny Mahlangu
- Professor Koji Eto
- Professor Lucy Chappell
- Professor Mads Krogsgaard Thomsen
- Professor Michel Michaelides
- Professor Naveed Sattar
- Professor Nurxat Nuraje
- Professor Paul Morgan
- Professor Peter Openshaw
- Professor Rob Howard
- Professor Robin Ali
- Professor Sarfaraz Niazi
- Professor Susumu Saito
- Professor Tara Spires-Jones
- Professor Ugur Sahin
- Professor Yongjin Zhou
- Professor Yukiya Kitayama
- Professor Zoe Kourtzi
- Professor Andrew Menzies-Gow
- Professor Lars Öhrström
- progressive pulmonary fibrosis (PPF)
- Prolia (denosumab)
- Pro-Liance Global Solutions
- Prometheus Biosciences
- prophylactic vaccine
- ProPublica
- Prostate cancer
- Protak Scientific Limited
- Protalix BioTherapeutics Inc
- Protein Crystallisation
- protein kinases
- protein structure
- PRX–102 (pegunigalsidase alfa)
- psilocybin
- Psoriasis
- Psoriatic arthritis
- psoriatic arthritis (PsA)
- psychedelics
- PT010 (budesonide/glycopyrronium/formoterol fumarate)
- PTC Therapeutics
- pulmonary arterial hypertension (PAH)
- Purdue University
- PureTech Health
- Pushkal Garg
- Pyzchiva (ustekinumab)
- QN-139b
- Quadrant Pharmaceuticals Limited
- Quality by Design (QbD)
- Quality, microbiology and contamination control
- Queen’s University Belfast
- Quotient
- Quotient Sciences
- rAAV8.hRKp.AIPL1
- Rachael Anatol
- radiographic axial spondyloarthritis
- radioligand therapy
- radiopharmaceutical
- Radiopharmaceuticals
- Rain Newton-Smith
- Rajiv Vaidya (Andelyn Biosciences)
- Raju Mohan
- Ralf Kuhlen
- Ralph Holme
- Raman Spectroscopy
- Rani Therapeutics
- ranibizumab
- Rao Kandula (Medipost)
- rapamycin
- rapid endotoxin testing
- Rapid Micro Biosystems
- Rapid Microbiological Methods (RMMs)
- Rare diseases
- Rare diseases
- Ratio Therapeutics
- Raw materials and supply chain (bioprocess)
- RC148
- Rebecca Guntern
- Reblozyl
- ReciBioPharm
- Recipharm
- Recruitment
- Recursion Pharmaceuticals
- refractory systemic sclerosis
- Regeneron
- Regeneron Pharmaceuticals
- Regenxbio
- Regis Simard
- Regulation and compliance
- Regulus Therapeutics
- ReiThera Srl
- Rekambys
- relapsed or refractory multiple myeloma (RRMM)
- Remco Jan Geukes Foppen
- RemeGen
- renal cell carcinoma (RCC)
- Rentschler Biopharma
- Research and Markets
- Research Square
- Respiratory diseases
- respiratory infection
- respiratory syncytial virus (RSV)
- respiratory syncytial virus (RSV)-mediated lower respiratory tract disease
- restenosis
- Retevmo
- retinal dystrophy
- retinal vein occlusion
- Retinitis Pigmentosa (RP)
- Revolution Biomanufacturing
- Rezolsta
- Rezon Bio
- RezonBio
- Rheumatoid arthritis (RA)
- Rice University
- Richard Francis
- Richard Gonzalez
- Richard Lowenthal
- Richard Ong (Medipost)
- Richard Parker
- Richard Saynor
- Richard Torbett
- Rick Suarez
- rilonacept
- rilpivirine
- Rinvoq
- RINVOQ (upadacitinib)
- risperidone (Risperdal)
- rituximab
- Riulvy (tegomil fumarate)
- rivaroxaban
- RNA
- RNA
- RNAi
- Robb Knie
- Robb Knie (Hoth Therapeutics)
- Robert Bradway
- Robert Brown
- Robert Califf
- Robert Davis
- Robert F Kennedy Jr
- Robert Michael
- Robert Plenge
- Robert Ring
- Robert Wessman
- Robotics
- Roche
- Roctavian (valoctocogene roxaparvovec)
- Rohan Palekar
- Rois
- Rolcya (denosumab)
- Ronapreve
- Roopal Thakkar
- Roslin CT
- Rovi
- Rubix Health
- Ruth Gimeno
- Ruud Dobber
- RVT-3101
- Rxulti
- Ryan Guest
- Rybelsus (oral semaglutide)
- Rybrevant
- RYBREVANT® (amivantamab)
- Ryeqo (relugolix/estradiol/norethisterone acetate)
- RYTELO™ (imetelstat)
- Sabine Bessières Recasens (Millipore SAS)
- Samabriva
- Samarth Kulkarni
- Sampling and sample preparation
- Samsung Bioepis
- Samsung Biologics
- Sanat Chattopadhyay
- Sandoz
- Sandoz Inc
- Sang Hoon Lee
- Sangmin Paik (Samsung Biologics)
- Sanner
- Sanofi
- Sara Panigone
- Sarah Moores
- Sarclisa (isatuximab)
- sarcoma
- Sarepta Therapeutics
- SARS-CoV-2
- Sartorius
- Sartorius AG
- Sartorius Bioseparations
- Saxenda
- Schedio SA
- Schizophrenia
- Schneider Electric
- Scholar Rock
- SCHOTT Pharmaceutical Systems
- Scottish Medicines Consortium (SMC)
- Seagen
- Sean Cunningham
- Sebastian Arana
- Sebnem Avsar Tuna
- seizures
- Semaglutide
- Sentynl Therapeutics
- Seongjin Kim (Samsung Biologics)
- Seong-Soo Park
- Sephience
- sepiapterin
- Sepsis
- Sequencing
- Serge Messerlian
- Servier
- severe aplastic anaemia (SAA)
- Sezary syndrome
- SFL Pharmaceuticals Deutschland
- SGS Health Science
- SGS Health Science
- SGS Life Sciences
- Shanghai JMT-Bio Technology
- Sharon Barr
- Shashank Deshpande
- Shelagh McKinlay
- Sherri Hopple (Charles River)
- Shimadzu
- Shimadzu Corporation
- Shingles
- Show Preview
- Shreya Athalye
- Shuyeb Muquit
- sickle cell disease
- Sidley Austin
- Siemens
- Sieving & Filtration
- Silvia Forroova (Informa Markets)
- Simponi (golimumab)
- Single Use
- Single Use Support
- Sir Adrian Smith
- Sir Patrick Vallance
- siRNA
- siRNA Therapeutics
- Sirolimus
- SiteOne Therapeutics
- Sivextro
- SixPeaks
- Sjögren’s disease
- SK pharmteco
- Skin cancer
- Skojoy (aflibercept)
- SKYCLARYS (omaveloxolone)
- Skyepharma
- Skytrofa
- Slenyto
- small cell lung cancer (SCLC)
- Small interfering RNA (siRNA)
- Small Pharma
- Sohonos (palovarotene)
- solid tumours
- Soliris (eculizumab)
- somatrogon
- sonpiretigene isteparvovec
- sonrotoclax
- Sophie Løhde
- Sotyktu (deucravacitinib)
- Spark Therapeutics
- Spectroscopy and imaging
- spesolimab
- Spevigo
- Spikevax
- Spinal muscular atrophy (SMA)
- spinocerebellar ataxia type 3
- spondyloarthritis
- Spravato (esketamine)
- Spray Drying
- SpringWorks Therapeutics
- SPX-001
- Sridevi Khambhampaty
- STADA
- Stanford Medicine
- Stargardt disease
- STC-004
- steatotic liver disease
- Stefan Haefliger
- Stefan Oelrich
- Stefano Colloca
- Steffen Lang (Novartis)
- Steffen Saltofte
- Stelara
- Stelara (ustekinumab)
- Stemline Therapeutics
- Stéphane Bancel
- Stephen Harrington (Likarda)
- Stephen Ward (CGT Catapult)
- Sterility and rapid methods
- Steve Barclay
- Steve Bates OBE
- Steve Brooks (AMR Industry Alliance)
- Stratus Technologies
- Stroke
- Stuart Grant
- Suanfarma
- Subin Baral (EY Global)
- Supemtek Tetra
- survodutide
- Susan Galbraith
- Susan Taylor Martin
- Susana Almeida
- Susann Brady-Kalnay
- Susvimo
- sutezolid
- Sven Dethlefs
- Swagatam Mukhopadhyay
- Swissmedic
- SWOG Cancer Research Network
- SYFOVRE (pegcetacoplan injection)
- Sylvester Comprehensive Cancer Center
- Symbiosis Pharmaceutical Services
- Syneos Health
- Syngene
- Syngene International Limited
- synovial sarcoma
- systemic sclerosis
- SystImmune
- Tagrisso (osimertinib)
- Taiwan Institute of Economic Research
- Takayuki Horiuchi
- Takeda
- Takeda Pharmaceutical Company Limited
- Takeda Pharmaceuticals
- Talquetamab
- TALZENNA® (talazoparib)
- TAPI
- TAR-200
- Tara Dougal
- Tarlatamab
- Taxane
- T-cell therapy
- TCS ADD
- TECELRA (afamitresgene autoleucel)
- Tecentriq
- Technical University of Denmark
- Technology
- Tecvayli (teclistamab)
- Teizeild
- tenofovir disoproxil fumarate (TDF)
- Tepezza (teprotumumab-trbw)
- Tepkinly® (epcoritamab)
- Teplizumab
- Teresa Siegert (FAU Erlangen-Nürnberg)
- Teriparatide
- Teriparatide Ascend (teriparatide)
- Tessellate Bio
- Tessera Therapeutics
- Teva
- Teva Pharmaceutical Industries Ltd
- Teva Pharmaceuticals
- Tevimbra
- Texas Heart Institute
- Tezspire (tezepelumab)
- The All Wales Therapeutics and Toxicology Centre (AWTTC)
- The Janssen Pharmaceutical Companies of Johnson & Johnson
- The Medicines and Healthcare products Regulatory Agency (MHRA)
- The National Institute for Health and Care Excellence (NICE)
- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
- The Pistoia Alliance
- The United States Pharmacopeia (USP)
- The United States Pharmacopoeia (USP)
- The University of Texas
- The University of Texas MD Anderson Cancer Center
- The US Food and Drug Administration (FDA)
- The World Health Organization (WHO)
- Therapeutics
- Thermal Analysis
- Thermo Fischer Scientific Inc.
- Thermo Fisher Scientific
- Thermo Fisher Scientific
- Thermo Fisher Scientific (Patheon)
- Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Pharma Services
- Thierry Van Nieuwenhove
- Thomas Schinecker
- Thomas Triomphe
- thrombocytopenia
- thyroid eye disease (TED)
- Tibsovo (ivosidenib)
- Ticlopidine Hydrochloride
- Tim Clackson
- Tim Lowery
- Tim Sandle
- Tim Sandle (Bio Products Laboratory and University of Manchester)
- Tim Sandle (Bio Products Laboratory)
- Timothy Maines
- Tirzepatide
- Tivdak (tisotumab vedotin)
- TKI
- Tofersen
- Tom Bujold (REGENXBIO)
- Tom Grinyer
- Tom Hegarty (Almac Pharma Services)
- Tom Keith-Roach
- Tomislav Sokol
- Tommy Schornak (Kindeva)
- Tony Acciarito
- Tony Carpanzano (JRS Pharma)
- Tony Cundell (Microbiological Consulting
- Tony Gurney
- Tony Wood
- Torkel Gren (Recipharm)
- Tourmaline Bio
- Towards Heathcare
- Toxicology
- TQ Therapeutics
- TQB-2102
- Trabectedin Accord (trabectedin)
- Tracy Beth Høeg
- Tradjenta (linagliptin)
- transfusion-dependent beta thalassemia
- Translarna (ataluren)
- transthyretin (ATTR) amyloidosis with cardiomyopathy
- transthyretin amyloid cardiomyopathy (ATTR-CM)
- trastuzumab
- Treatment-resistant depression (TRD)
- Tremfya
- TREMFYA® (guselkumab)
- Trixeo Aerosphere
- troriluzole hydrochloride monohydrate
- Trulicity
- Trulicity (dulaglutide)
- Truqap
- Truvada
- TSRA-196
- Tuberculosis
- Tufts University
- Tulane University
- tulisokibart
- Tumours
- Type 1 Diabetes
- Type 2 Diabetes
- Type 2 Diabetes Mellitus (T2DM)
- tyrosine kinase inhibitor
- Tzield
- U.S. Food and Drug Administration (FDA)
- UCB
- UCB Pharma
- Ugur Sahin
- UK BioIndustry Association (BIA)
- UK Department of Health and Social Care (DHSC)
- UK Government
- UK Medicines and Healthcare products Regulatory Agency (MHRA)
- Ulcerative colitis (UC)
- Ultomiris
- Ultrasound
- Under the Microscope
- Uniphar
- uniQure
- United States Pharmacopeia (USP)
- University College London (UCL)
- University College London Great Ormond Street Institute of Child Health (UCL ICH)
- University of Birmingham
- University of California
- University of California Santa Barbara
- University of Cambridge
- University of Cincinnati
- University of Glasgow
- University of Leeds
- University of Liege
- University of Liverpool
- University of Manchester
- University of Maryland
- University of Oxford
- University of Pennsylvania
- University of Sheffield
- University of Texas MD Anderson Cancer Center
- Upstaza™
- Upstream processing
- urinary infection
- urinary tract infections
- Ursula von der Leyen
- Urte Jakimaviciute
- US Department of Health and Human Services (HHS)
- US Department of the Health and Human Services (HHS)
- US Federal Trade Commission (FTC)
- US Food and Drug Administration
- US Food and Drug Administration (FDA)
- US Food and Drug Administrattion (FDA)
- US National Institutes of Health (NIH)
- US Pharmacopeia (USP)
- Ustekinumab
- Ute Lehmann
- Vabysmo (faricimab)
- Vaccine Technology
- vaccines
- Valneva
- ValSource
- Van Hoang (Spark Therapeutics)
- Vanessa Vasadi Figueroa
- Vanflyta (quizartinib)
- vanzacaftor/tezacaftor/deutivacaftor
- Vas Narasimhan
- Veklury
- Vela
- venetoclax
- Ventolin (salbutamol)
- Ventyx Biosciences
- Veolia
- Veolia Water Technologies & Solutions
- vepdegestrant
- Verified Market Reports
- Verified Market Research
- Verona Pharma
- Vertex Pharmaceuticals
- Verve Therapeutics
- VERVE-102
- Verzenio
- Vevzuo
- VG-3927
- Viatris
- Vicebio
- ViiV Healthcare
- Vimkunya (chikungunya vaccine (recombinant
- Vinay Prasad
- Vincenzo Gioia
- viral infections
- Virtual reality (VR)
- Viruses
- Vish Seshadri
- Vitiligo
- Vocabria (cabotegravir)
- VTT Technical Research Centre of Finland
- VVF Science
- VWV
- VXB-241
- Vydura (rimegepant)
- Vyjuvek (beremagene geperpavec)
- VYJUVEK™ (beremagene geperpavec-svdt)
- Vyvgart (efgartigimod alfa)
- Wa’el Hashad
- Wafaa Hassan
- Waskyra (etuvetidigene autotemcel)
- Waters
- Waters Corporation
- Wegovy (semaglutide)
- Wegovy™
- Wellcome Trust
- Wes Streeting
- West Pharmaceutical Services
- wet age-related macular degeneration
- Wheeler Bio
- Whit Bernard
- Will Frost
- Winlevi (clascoterone)
- Wiskott–Aldrich syndrome (WAS)
- Women Inspiring Pharma
- World Health Organisation (WHO)
- World Health Organization (WHO)
- Worldwide Clinical Trials
- WuXi AppTec
- WuXi Biologics
- WuXi STA
- WuXi XDC
- Wyost® (denosumab-bddz)
- Xavier Baville
- XenoStart
- Xgeva
- Xofluza
- Xolair (omalizumab)
- Xtandi (enzalutamide)
- Yaohui Ji
- YaoPharma
- Yaxwer
- Yervoy
- Yescarta
- Yescarta (axicabtagene ciloleucel)
- YESINTEK
- Ying Chen
- Yolanda Gomez
- YP05002
- Ypsomed Group
- Yutaka Yamaguchi
- Yvonne Greenstreet
- Zadenvi
- zanidatamab
- Zentiva
- Zepbound (tirzepatide)
- Zevaskyn (prademagene zamikeracel)
- Zhejian Cao
- Ziihera
- Zilbrysq (zilucoplan)
- zilebesiran
- Zina Chatzidimitriadou
- Zolgensma (onasemnogene abeparvovec)
- Zoonotic Influenza Vaccine Seqirus
- Ztalmy (ganaxolone)
- Zuranolone
- Zurzuvae
- Zycubo (copper histidinate)